Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Small molecules– Market size and forecast 2017-2022 • Biologics – Market size and forecast 2017-2022 • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increased demand for regenerative medicine • Increased number of M&A • Presence of value-added services PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Charles River • Domainex • EVOTEC • GenScript • GVK Biosciences • Laboratory Corporation of America • Other prominent vendors PART 15: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global drug discovery outsourcing market – Market size and forecast 2017-2022 ($ bn) Exhibit 08: Global drug discovery outsourcing market – Year over year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017-2022 Exhibit 17: Product – Market share 2017-2022 (%) Exhibit 18: Comparison by product Exhibit 19: Small molecules– Market size and forecast 2017-2022 ($ bn) Exhibit 20: Characteristics of small molecules drugs compared with biologics Exhibit 21: Small molecules– Year over year growth 2018-2022 (%) Exhibit 22: Biologics– Market size and forecast 2017-2022 ($ bn) Exhibit 23: Biologics– Year over year growth 2018-2022 (%) Exhibit 24: Popular biologics Exhibit 25: Market opportunity by product Exhibit 26: Customer landscape Exhibit 27: Global – Market share by geography 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 30: Americas – Year over year growth 2018-2022 (%) Exhibit 31: Top three countries in Americas Exhibit 32: EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 33: EMEA – Year over year growth 2018-2022 (%) Exhibit 34: Top three countries in EMEA Exhibit 35: APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 36: APAC – Year over year growth 2018-2022 (%) Exhibit 37: Top three countries in APAC Exhibit 38: Market opportunity Exhibit 39: Competitive advantage among vendors Exhibit 40: Examples of global pharmaceutical companies sourcing from contract manufacturers Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendors Covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Vendor overview Exhibit 48: Charles River – Business segments Exhibit 49: Charles River – Organizational developments Exhibit 50: Charles River – Geographic focus Exhibit 51: Charles River – Segment focus Exhibit 52: Charles River – Key offerings Exhibit 53: Vendor overview Exhibit 54: Domainex – Business segments Exhibit 55: Domainex – Organizational developments Exhibit 56: Domainex – Geographic focus Exhibit 57: Domainex – Segment focus Exhibit 58: Domainex – Key offerings Exhibit 59: Vendor overview Exhibit 60: EVOTEC– Business segments Exhibit 61: EVOTEC– Organizational developments Exhibit 62: EVOTEC– Geographic focus Exhibit 63: EVOTEC– Segment focus Exhibit 64: EVOTEC– Key offerings Exhibit 65: Vendor overview Exhibit 66: GenScript– Business segments Exhibit 67: GenScript– Organizational developments Exhibit 68: GenScript– Geographic focus Exhibit 69: GenScript– Segment focus Exhibit 70: GenScript– Key offerings Exhibit 71: Vendor overview Exhibit 72: GVK Biosciences– Business segments Exhibit 73: GVK Biosciences– Organizational developments Exhibit 74: GVK Biosciences– Geographic focus Exhibit 75: GVK Biosciences– Segment focus Exhibit 76: GVK Biosciences– Key offerings Exhibit 77: Vendor overview Exhibit 78: Laboratory Corporation of America– Business segments Exhibit 79: Laboratory Corporation of America– Organizational developments Exhibit 80: Laboratory Corporation of America– Geographic focus Exhibit 81: Laboratory Corporation of America– Segment focus Exhibit 82: Laboratory Corporation of America– Key offerings

Charles River, Domainex, EVOTEC, GenScript, and GVK Biosciences.